Key Insights

Highlights

Treatment Research

3 treatments under study, led by Reverse Scan Body Digital Impression

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Recruiting1

Clinical Trials (1)

Research Network

Common Treatments

  • Reverse Scan Body Digital Impression1
  • Ioconnect Digital Impression1
  • Conventional Splinted Impression1

Active Sponsors

  • Mansoura University1

Top Investigators

Related Conditions

  • Dental Implants1
  • Edentulous Jaw1

Activity Timeline